{
  "schemaVersion" : 2,
  "registerId" : "F2017C00818",
  "instrumentNumber" : "23/2012",
  "citation" : "Statement of Principles concerning atherosclerotic peripheral vascular disease No. 23 of 2012",
  "conditionName" : "atherosclerotic peripheral vascular disease",
  "effectiveFrom" : "2012-03-07",
  "standardOfProof" : "Reasonable Hypothesis",
  "icdCodes" : [ {
    "version" : "ICD-10-AM",
    "code" : "I70.2"
  } ],
  "onsetFactors" : [ {
    "paragraph" : "6(a)",
    "text" : "smoking at least five pack-years, or the equivalent thereof in other\r\ntobacco products, before the clinical onset of atherosclerotic peripheral\r\nvascular disease, and where smoking has ceased, the clinical onset of\r\natherosclerotic peripheral vascular disease has occurred within 20 years\r\nof cessation",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(b)",
    "text" : "having diabetes mellitus before the clinical onset of atherosclerotic\r\nperipheral vascular disease",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(c)",
    "text" : "having hypertension before the clinical onset of atherosclerotic\r\nperipheral vascular disease",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(d)",
    "text" : "having dyslipidaemia before the clinical onset of atherosclerotic\r\nperipheral vascular disease",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(e)",
    "text" : "having hyperhomocysteinaemia before the clinical onset of\r\natherosclerotic peripheral vascular disease",
    "definedTerms" : [ {
      "term" : "hyperhomocysteinaemia",
      "definition" : "means a condition characterised by an excess of\nhomocysteine in the blood"
    } ]
  }, {
    "paragraph" : "6(f)",
    "text" : "having chronic renal disease before the clinical onset of atherosclerotic\r\nperipheral vascular disease",
    "definedTerms" : [ {
      "term" : "chronic renal disease",
      "definition" : "means irreversible kidney damage which leads to\nimpaired renal function"
    } ]
  }, {
    "paragraph" : "6(g)",
    "text" : "having received a cumulative equivalent dose of at least 0.5 sievert of\r\nionising radiation to the affected artery before the clinical onset of\r\natherosclerotic peripheral vascular disease",
    "definedTerms" : [ {
      "term" : "cumulative equivalent dose",
      "definition" : "means the total dose of ionising radiation\nreceived by the particular organ or tissue from external exposure, internal\nexposure or both, apart from normal background radiation exposure in\nAustralia, calculated in accordance with the methodology set out in Guide to\ncalculation of 'cumulative equivalent dose' for the purpose of applying\nionising radiation factors contained in Statements of Principles determined\nunder Part XIA of the Veterans' Entitlements Act 1986 (Cth), Australian\nRadiation Protection and Nuclear Safety Agency, as in force on 2 August\n2017;\nNote 1: Examples of circumstances that might lead to exposure to ionising radiation include\nbeing present during or subsequent to the testing or use of nuclear weapons,\nundergoing diagnostic or therapeutic medical procedures involving ionising radiation,\nand being a member of an aircrew, leading to increased levels of exposure to cosmic\nradiation.\nNote 2: For the purpose of dose reconstruction, dose is calculated as an average over the mass\nof a specific tissue or organ. If a tissue is exposed to multiple sources of ionising\nradiation, the various dose estimates for each type of radiation must be combined"
    } ]
  }, {
    "paragraph" : "6(h)",
    "text" : "undergoing a course of therapeutic radiation for cancer, where the\r\naffected artery was in the field of radiation, before the clinical onset of\r\natherosclerotic peripheral vascular disease",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(i)",
    "text" : "being in an atmosphere with a visible tobacco smoke haze in an\r\nenclosed space for at least 5000 hours before the clinical onset of\r\natherosclerotic peripheral vascular disease, where the last exposure to\r\nthat atmosphere occurred within the five years before the clinical onset\r\nof atherosclerotic peripheral vascular disease",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(j)",
    "text" : "having periodontitis for at least the two years before the clinical onset\r\nof atherosclerotic peripheral vascular disease",
    "definedTerms" : [ ]
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "6(k)",
    "text" : "smoking at least five pack-years, or the equivalent thereof in other\r\ntobacco products, before the clinical worsening of atherosclerotic\r\nperipheral vascular disease, and where smoking has ceased, the clinical\r\nworsening of atherosclerotic peripheral vascular disease has occurred\r\nwithin 20 years of cessation",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(l)",
    "text" : "having diabetes mellitus before the clinical worsening of\r\natherosclerotic peripheral vascular disease",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(m)",
    "text" : "having hypertension before the clinical worsening of atherosclerotic\r\nperipheral vascular disease",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(n)",
    "text" : "having dyslipidaemia before the clinical worsening of atherosclerotic\r\nperipheral vascular disease",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(o)",
    "text" : "having hyperhomocysteinaemia before the clinical worsening of\r\natherosclerotic peripheral vascular disease",
    "definedTerms" : [ {
      "term" : "hyperhomocysteinaemia",
      "definition" : "means a condition characterised by an excess of\nhomocysteine in the blood"
    } ]
  }, {
    "paragraph" : "6(p)",
    "text" : "having chronic renal disease before the clinical worsening of\r\natherosclerotic peripheral vascular disease",
    "definedTerms" : [ {
      "term" : "chronic renal disease",
      "definition" : "means irreversible kidney damage which leads to\nimpaired renal function"
    } ]
  }, {
    "paragraph" : "6(q)",
    "text" : "having received a cumulative equivalent dose of at least 0.5 sievert of\r\nionising radiation to the affected artery before the clinical worsening of\r\natherosclerotic peripheral vascular disease",
    "definedTerms" : [ {
      "term" : "cumulative equivalent dose",
      "definition" : "means the total dose of ionising radiation\nreceived by the particular organ or tissue from external exposure, internal\nexposure or both, apart from normal background radiation exposure in\nAustralia, calculated in accordance with the methodology set out in Guide to\ncalculation of 'cumulative equivalent dose' for the purpose of applying\nionising radiation factors contained in Statements of Principles determined\nunder Part XIA of the Veterans' Entitlements Act 1986 (Cth), Australian\nRadiation Protection and Nuclear Safety Agency, as in force on 2 August\n2017;\nNote 1: Examples of circumstances that might lead to exposure to ionising radiation include\nbeing present during or subsequent to the testing or use of nuclear weapons,\nundergoing diagnostic or therapeutic medical procedures involving ionising radiation,\nand being a member of an aircrew, leading to increased levels of exposure to cosmic\nradiation.\nNote 2: For the purpose of dose reconstruction, dose is calculated as an average over the mass\nof a specific tissue or organ. If a tissue is exposed to multiple sources of ionising\nradiation, the various dose estimates for each type of radiation must be combined"
    } ]
  }, {
    "paragraph" : "6(r)",
    "text" : "undergoing a course of therapeutic radiation for cancer, where the\r\naffected artery was in the field of radiation, before the clinical\r\nworsening of atherosclerotic peripheral vascular disease",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(s)",
    "text" : "being in an atmosphere with a visible tobacco smoke haze in an\r\nenclosed space for at least 5000 hours before the clinical worsening of\r\natherosclerotic peripheral vascular disease, where the last exposure to\r\nthat atmosphere occurred within the five years before the clinical\r\nworsening of atherosclerotic peripheral vascular disease",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(t)",
    "text" : "having periodontitis for at least the two years before the clinical\r\nworsening of atherosclerotic peripheral vascular disease",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(u)",
    "text" : "an inability to undertake any physical activity greater than three METs\r\nfor at least the five years before the clinical worsening of\r\natherosclerotic peripheral vascular disease",
    "definedTerms" : [ {
      "term" : "MET",
      "definition" : "means a unit of measurement of the level of physical exertion. 1\nMET = 3.5 ml of oxygen/kg of body weight per minute or, 1.0 kcal/kg of body\nweight per hour, or resting metabolic rate"
    } ]
  }, {
    "paragraph" : "6(v)",
    "text" : "inability to obtain appropriate clinical management for atherosclerotic\r\nperipheral vascular disease",
    "definedTerms" : [ ]
  } ]
}